Geron Corporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Geron with three other
companies in this sector in the United States:
Prothena Corporation PLC
sales of $955,000.00
of which 100%
Avecho Biotechnology Ltd
Cue Biopharma Inc
During the year ended December of 2018, sales at
Geron were $1.07 million.
a very small
increase of 0.1%
versus 2017, when the company's sales were $1.07 million.
Despite this increase, sales are still
below the level achieved in 2016, when Geron
reported sales of $6.16 million.